Ticker Scorecard - RVMD Basics Company: Revolution Medicines, Inc. IPO Date: February 13, 2020 Sector: Healthcare Industry: Biotech Market Cap: $7.64B Activated in VL: True Average Daily Range Avg Daily Range: $0.82 | 2.76% Avg Daily Range (30 D): $0.70 | 1.67% Avg Daily Range (90 D): $0.86 | 1.79% Institutional Daily Volume Avg Daily Volume: .77M Avg Daily Volume (30 D): 1.05M Avg Daily Volume (90 D): 1.17M Trade Size Avg Trade Size (Sh.): 72 Avg Trade Size (Sh.) (30 D): 59 Avg Trade Size (Sh.) (90 D): 63 Institutional Trades Total Inst.Trades: 3,827 Avg Inst. Trade: $2.87M Avg Inst. Trade (30 D): $3.17M Avg Inst. Trade (90 D): $3.52M Avg Inst. Trade Volume: .09M Avg Inst. Trades (Per Day): 3 Market Closing Trades Avg Closing Trade: $5.05M Avg Closing Trade (30 D): $8.39M Avg Closing Trade (90 D): $10.91M Avg Closing Volume: 161.67K     News Jul 16, 2024 @ 12:16 PM Top 3 Health Care Stocks That Should Keep You Up A... Source: Avi Kapoor Jul 16, 2024 @ 12:05 PM Microsoft To Rally Around 6%? Here Are 10 Top Anal... Source: Avi Kapoor Jul 11, 2024 @ 4:02 PM Revolution Medicines Announces Publication Demonst... Source: Revolution Medicines, Inc. Jun 5, 2024 @ 8:05 PM Revolution Medicines to Participate in Goldman Sac... Source: Revolution Medicines, Inc. May 8, 2024 @ 8:02 PM Revolution Medicines Reports First Quarter 2024 Fi... Source: Revolution Medicines, Inc. Financials   TTM Q3 2024 Q2 2024 Basic EPS $-3.66 $-.94 $-.81 Diluted EPS $-3.66 $-.94 $-.81 Revenue $ .74M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -567.06M $ -156.29M $ -133.23M Operating Income / Loss $ -653.2M $ -175.71M $ -156.64M Cost of Revenue $ $ $ Net Cash Flow $ -156.64M $ -74.59M $ -12.72M PE Ratio